Cargando…
SLM Produced Porous Titanium Implant Improvements for Enhanced Vascularization and Osteoblast Seeding
To improve well-known titanium implants, pores can be used for increasing bone formation and close bone-implant interface. Selective Laser Melting (SLM) enables the production of any geometry and was used for implant production with 250-µm pore size. The used pore size supports vessel ingrowth, as b...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425029/ https://www.ncbi.nlm.nih.gov/pubmed/25849656 http://dx.doi.org/10.3390/ijms16047478 |
_version_ | 1782370425885425664 |
---|---|
author | Matena, Julia Petersen, Svea Gieseke, Matthias Kampmann, Andreas Teske, Michael Beyerbach, Martin Murua Escobar, Hugo Haferkamp, Heinz Gellrich, Nils-Claudius Nolte, Ingo |
author_facet | Matena, Julia Petersen, Svea Gieseke, Matthias Kampmann, Andreas Teske, Michael Beyerbach, Martin Murua Escobar, Hugo Haferkamp, Heinz Gellrich, Nils-Claudius Nolte, Ingo |
author_sort | Matena, Julia |
collection | PubMed |
description | To improve well-known titanium implants, pores can be used for increasing bone formation and close bone-implant interface. Selective Laser Melting (SLM) enables the production of any geometry and was used for implant production with 250-µm pore size. The used pore size supports vessel ingrowth, as bone formation is strongly dependent on fast vascularization. Additionally, proangiogenic factors promote implant vascularization. To functionalize the titanium with proangiogenic factors, polycaprolactone (PCL) coating can be used. The following proangiogenic factors were examined: vascular endothelial growth factor (VEGF), high mobility group box 1 (HMGB1) and chemokine (C-X-C motif) ligand 12 (CXCL12). As different surfaces lead to different cell reactions, titanium and PCL coating were compared. The growing into the porous titanium structure of primary osteoblasts was examined by cross sections. Primary osteoblasts seeded on the different surfaces were compared using Live Cell Imaging (LCI). Cross sections showed cells had proliferated, but not migrated after seven days. Although the cell count was lower on titanium PCL implants in LCI, the cell count and cell spreading area development showed promising results for titanium PCL implants. HMGB1 showed the highest migration capacity for stimulating the endothelial cell line. Future perspective would be the incorporation of HMGB1 into PCL polymer for the realization of a slow factor release. |
format | Online Article Text |
id | pubmed-4425029 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-44250292015-05-20 SLM Produced Porous Titanium Implant Improvements for Enhanced Vascularization and Osteoblast Seeding Matena, Julia Petersen, Svea Gieseke, Matthias Kampmann, Andreas Teske, Michael Beyerbach, Martin Murua Escobar, Hugo Haferkamp, Heinz Gellrich, Nils-Claudius Nolte, Ingo Int J Mol Sci Article To improve well-known titanium implants, pores can be used for increasing bone formation and close bone-implant interface. Selective Laser Melting (SLM) enables the production of any geometry and was used for implant production with 250-µm pore size. The used pore size supports vessel ingrowth, as bone formation is strongly dependent on fast vascularization. Additionally, proangiogenic factors promote implant vascularization. To functionalize the titanium with proangiogenic factors, polycaprolactone (PCL) coating can be used. The following proangiogenic factors were examined: vascular endothelial growth factor (VEGF), high mobility group box 1 (HMGB1) and chemokine (C-X-C motif) ligand 12 (CXCL12). As different surfaces lead to different cell reactions, titanium and PCL coating were compared. The growing into the porous titanium structure of primary osteoblasts was examined by cross sections. Primary osteoblasts seeded on the different surfaces were compared using Live Cell Imaging (LCI). Cross sections showed cells had proliferated, but not migrated after seven days. Although the cell count was lower on titanium PCL implants in LCI, the cell count and cell spreading area development showed promising results for titanium PCL implants. HMGB1 showed the highest migration capacity for stimulating the endothelial cell line. Future perspective would be the incorporation of HMGB1 into PCL polymer for the realization of a slow factor release. MDPI 2015-04-02 /pmc/articles/PMC4425029/ /pubmed/25849656 http://dx.doi.org/10.3390/ijms16047478 Text en © 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Matena, Julia Petersen, Svea Gieseke, Matthias Kampmann, Andreas Teske, Michael Beyerbach, Martin Murua Escobar, Hugo Haferkamp, Heinz Gellrich, Nils-Claudius Nolte, Ingo SLM Produced Porous Titanium Implant Improvements for Enhanced Vascularization and Osteoblast Seeding |
title | SLM Produced Porous Titanium Implant Improvements for Enhanced Vascularization and Osteoblast Seeding |
title_full | SLM Produced Porous Titanium Implant Improvements for Enhanced Vascularization and Osteoblast Seeding |
title_fullStr | SLM Produced Porous Titanium Implant Improvements for Enhanced Vascularization and Osteoblast Seeding |
title_full_unstemmed | SLM Produced Porous Titanium Implant Improvements for Enhanced Vascularization and Osteoblast Seeding |
title_short | SLM Produced Porous Titanium Implant Improvements for Enhanced Vascularization and Osteoblast Seeding |
title_sort | slm produced porous titanium implant improvements for enhanced vascularization and osteoblast seeding |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425029/ https://www.ncbi.nlm.nih.gov/pubmed/25849656 http://dx.doi.org/10.3390/ijms16047478 |
work_keys_str_mv | AT matenajulia slmproducedporoustitaniumimplantimprovementsforenhancedvascularizationandosteoblastseeding AT petersensvea slmproducedporoustitaniumimplantimprovementsforenhancedvascularizationandosteoblastseeding AT giesekematthias slmproducedporoustitaniumimplantimprovementsforenhancedvascularizationandosteoblastseeding AT kampmannandreas slmproducedporoustitaniumimplantimprovementsforenhancedvascularizationandosteoblastseeding AT teskemichael slmproducedporoustitaniumimplantimprovementsforenhancedvascularizationandosteoblastseeding AT beyerbachmartin slmproducedporoustitaniumimplantimprovementsforenhancedvascularizationandosteoblastseeding AT muruaescobarhugo slmproducedporoustitaniumimplantimprovementsforenhancedvascularizationandosteoblastseeding AT haferkampheinz slmproducedporoustitaniumimplantimprovementsforenhancedvascularizationandosteoblastseeding AT gellrichnilsclaudius slmproducedporoustitaniumimplantimprovementsforenhancedvascularizationandosteoblastseeding AT nolteingo slmproducedporoustitaniumimplantimprovementsforenhancedvascularizationandosteoblastseeding |